Anthera Pharmaceuticals Inc 4
4 · Anthera Pharmaceuticals Inc · Filed Dec 6, 2016
Insider Transaction Report
Form 4
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Award
Stock option (right to buy)
2016-12-06+300,000→ 300,000 totalExercise: $1.47Exp: 2026-12-06→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This stock option vests over four years as follows: 25% of the stock options shall vest one year following the vesting commencement date, with the remaining 75% of the stock options vesting in 36 equal monthly installments thereafter. The vesting commencement date is December 6, 2016.